NuVision Offers Pink LCD for Breast Cancer Awareness
Part of the proceeds from the limited edition HDTV will be donated to breast cancer research by NuVision.
NuVision’s limited-edition 32” HDTV
October 01, 2009 by Arlen Schweiger

Want to get your fix of high-definition TV and give to a worthy cause at the same time? Think pink.

October is Breast Cancer Awareness Month, and display manufacturer NuVision has created a pink-bezeled HDTV to help out the cause.

The 32-inch set is part of its high-performance Lucidium FX5 LCD Series and will be a limited-edition product. The company is donating a portion of the proceeds to breast cancer research.

Seemed like a no-brainer for the company—you may not have thought you wanted a pink TV, but now maybe you’ll think twice. “We wanted to bring a television to market that was different than anything else out there,” says NuVision vice chairman David Hester.  “We loved the idea of a pink-framed unit because it’s not only an alternative to traditional 32” displays, but because of the obvious ties to breast cancer research.  It’s not only important for us to manufacture high-end LCD’s, but we’d like to be known as a company that gives back as well.”

As for the TV itself, you’ll get the usual high-def goodies, with 1080p resolution, 120Hz flicker-free images, deep blacks and more. MSRP on the high-performance set is $1,499.

Follow Electronic House on Facebook and Twitter.

Arlen Schweiger - Contributor, Electronic House Magazine
Arlen writes about home technology installations and product news and reviews for and Electronic House magazine.

FREE Charter Platinum Membership
Claim your FREE Charter Platinum Membership to EH Network and receive 6 FREE issues of EH Magazine.*
First Name
Last Name
Email Address

We understand your email address is private. By granting you access to the EH Network, you agree to receive email communications from us, including our newsletters. You can manage your subscription at any time in the future.
* The new EH Network launches and your free subscription begins December 2014.


Commenting is not available in this weblog entry.